Search

Search Results

33 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

Page: 12 of 2

• ReviewVolume 12, Issue 3pp 3053-3094

  New landscapes and horizons in hepatocellular carcinoma therapy

  Relevance score: 0.00

  Melchiorre Cervello, Maria R. Emma, Giuseppa Augello, Antonella Cusimano, Lydia Giannitrapani, Maurizio Soresi, Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Alessandro Gulino, Beatrice Belmonte, Giuseppe Montalto, James A. McCubrey

  Keywords: HCC, targeted therapy, immunotherapy, aging, cancer

  Published in Aging on February 4, 2020

  Show abstract
• Research PaperVolume 14, Issue 8pp 3365-3386

  Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties

  Relevance score: 0.00

  James A. McCubrey, Akshaya K. Meher, Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Michelle M. LaHair, Richard A. Franklin, Alberto M. Martelli, Stefano Ratti, Lucio Cocco, Fulvio Barbaro, Przemysław Duda, Agnieszka Gizak

  Keywords: TP53, targeted therapy, PDAC, chemotherapeutic drugs, metabolic properties

  Published in Aging on April 27, 2022

  Show abstract
• EditorialVolume 7, Issue 11pp 899-900

  HER-3: hub for escape mechanisms

  Relevance score: 0.00

  Emily Capone, Pramudita R Prasetyanti, Gianluca Sala

  Keywords: HER-3, targeted therapy, drug resistance

  Published in Aging on November 18, 2015

• Research PaperVolume 15, Issue 1pp 119-133

  Profiling of a novel circadian clock-related prognostic signature and its role in immune function and response to molecular targeted therapy in pancreatic cancer

  Relevance score: 0.00

  Yu Jin, Shuang Gong, Guochen Shang, Lilin Hu, Gangping Li

  Keywords: circadian clock, neutrophil, pancreatic cancer, prognosis, targeted therapy

  Published in Aging on January 9, 2023

  Show abstract
• Research PaperVolume 12, Issue 18pp 18384-18395

  p38γ overexpression promotes osteosarcoma cell progression

  Relevance score: 0.00

  Ce Shi, Wei-Nan Cheng, Yin Wang, Da-Zhuang Li, Li-Na Zhou, Yu-Cheng Zhu, Xiao-Zhong Zhou

  Keywords: osteosarcoma, p38γ, molecularly targeted therapy

  Published in Aging on September 24, 2020

  Show abstract
• ReviewVolume 15, Issue 9pp 3857-3889

  Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment

  Relevance score: 0.00

  YanJun Zhang, Lijuan Zhan, Jing Li, Xue Jiang, Li Yin

  Keywords: m6A, ncRNA, tumor microenvironment, tumor metastasis, exosome, biomarker, targeted therapy

  Published in Aging on May 12, 2023

  Show abstract
• Research PaperVolume 15, Issue 4pp 1107-1129

  Prognostic significance of epidermal growth factor receptor and programmed cell death-ligand 1 co-expression in esophageal squamous cell carcinoma

  Relevance score: 0.00

  Guoxiang Jiang, Yandong Miao, Zhenbo Wang, Qi Zhang, Ping Zhou, Fang Zhang

  Keywords: esophageal cancer, squamous cell carcinoma, PD-L1, EGFR, targeted therapy

  Published in Aging on February 20, 2023

  Show abstract
• Research PaperVolume 14, Issue 15pp 6149-6168

  Interleukin-17D promotes lung cancer progression by inducing tumor-associated macrophage infiltration via the p38 MAPK signaling pathway

  Relevance score: 0.00

  Zhenzhen Lin, Qiumin Huang, Junrong Liu, Hao Wang, Xuexi Zhang, Zhiyan Zhu, Wei Zhang, Yiliang Wei, Zhe Liu, Wei Du

  Keywords: cytokine, IL-17D, lung cancer, MAPK signaling pathway, targeted therapy

  Published in Aging on August 5, 2022

  Show abstract
• Research PaperVolume 14, Issue 8pp 3464-3483

  Improving ovarian cancer treatment decision using a novel risk predictive tool

  Relevance score: 0.00

  Zhenyi Xu, Jiali Song, Lei Cao, Zhiwei Rong, Wenjie Zhang, Jia He, Kang Li, Yan Hou

  Keywords: tumor microenvironment, predictive factor, immunotherapy, targeted therapy, gene mutation

  Published in Aging on April 19, 2022

  Show abstract
• Research PaperVolume 13, Issue 24pp 26046-26062

  An immune-related lncRNA risk coefficient model to predict the outcomes in clear cell renal cell carcinoma

  Relevance score: 0.00

  Cheng Tang, GenYi Qu, Yong Xu, Guang Yang, Jiawei Wang, Maolin Xiang

  Keywords: TCGA database, clear cell renal cell carcinoma, immune-related lncRNA pairs, risk coefficient model, prognosis, tumor immune infiltration, targeted therapy

  Published in Aging on December 26, 2021

  Show abstract
• Research PaperVolume 13, Issue 20pp 23702-23725

  Selected ideal natural ligand against TNBC by inhibiting CDC20, using bioinformatics and molecular biology

  Relevance score: 0.00

  Naimeng Liu, Xinhui Wang, Zhu Zhu, Duo Li, Xiaye Lv, Yichang Chen, Haoqun Xie, Zhen Guo, Dong Song

  Keywords: CDC20, drug development, virtual screening, TNBC, targeted therapy

  Published in Aging on October 22, 2021

  Show abstract
• Research PaperVolume 13, Issue 19pp 22867-22882

  Computational study of effective matrix metalloproteinase 9 (MMP9) targeting natural inhibitors

  Relevance score: 0.00

  Naimeng Liu, Xinhui Wang, Hao Wu, Xiaye Lv, Haoqun Xie, Zhen Guo, Jing Wang, Gaojing Dou, Chenxi Zhang, Mindan Sun

  Keywords: MMP9, drug development, virtual screening, CCRCC, targeted therapy

  Published in Aging on October 4, 2021

  Show abstract
• Research PaperVolume 13, Issue 16pp 20246-20257

  Identification of effective natural PIK3CA H1047R inhibitors by computational study

  Relevance score: 0.00

  Naimeng Liu, Xinhui Wang, Xuan Li, Xiaye Lv, Haoqun Xie, Zhen Guo, Jing Wang, Gaojing Dou, Ye Du, Dong Song

  Keywords: PIK3CA H1047R, drug development, virtual screening, TNBC, targeted therapy

  Published in Aging on August 20, 2021

  Show abstract
• ReviewVolume 13, Issue 12pp 16859-16872

  Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17

  Relevance score: 0.00

  Guang Yang, Mengying Cui, Weibo Jiang, Jiyao Sheng, Yongsheng Yang, Xuewen Zhang

  Keywords: ADAM17, domain, human diseases, targeted therapy, miRNAs

  Published in Aging on June 28, 2021

  Show abstract
• Research PaperVolume 12, Issue 13pp 13059-13075

  Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway

  Relevance score: 0.00

  Yizhou Yao, Xuchao Wang, Diyuan Zhou, Hao Li, Huan Qian, Jiawen Zhang, Linhua Jiang, Bin Wang, Qi Lin, Xinguo Zhu

  Keywords: AKR1B10, colorectal cancer, FGF1, targeted therapy

  Published in Aging on July 2, 2020

  Show abstract
• EditorialVolume 9, Issue 6pp 1471-1472

  Synergistic immunotoxin-paclitaxel combination against lymphoma

  Relevance score: 0.00

  Fabian Müller

  Keywords: immunotoxin, paclitaxel, B-NHL, leukemia, targeted therapy, drug synergy, systemic xenograft model

  Published in Aging on June 13, 2017

• Letter to the EditorVolume 8, Issue 11pp 3147-3150

  The Fhit protein: an opportunity to overcome chemoresistance

  Relevance score: 0.00

  Eugenio Gaudio, Francesco Paduano, Carlo M. Croce, Francesco Trapasso

  Keywords: Fragile Histidine Triad (FHIT), tumor suppressor, reactive oxygen species, targeted therapy, mimetic peptides

  Published in Aging on November 12, 2016

• EditorialVolume 8, Issue 9pp 1834-1835

  BIM-mediated apoptosis and oncogene addiction

  Relevance score: 0.00

  Yulin Li, Anja Deutzmann, Dean W. Felsher

  Keywords: BIM, apoptosis, oncogene addiction, oncogene inactivation, targeted therapy

  Published in Aging on September 29, 2016

• EditorialVolume 7, Issue 12pp 1026-1027

  Fasting plus tyrosine kinase inhibitors in cancer

  Relevance score: 0.00

  Irene Caffa, Valter D. Longo, Alessio Nencioni

  Keywords: cancer, fasting, tyrosine kinase inhibitors, MAPK signaling, molecularly, targeted therapy

  Published in Aging on December 6, 2015

• EditorialVolume 8, Issue 10pp 2258-2259

  Combinations of targeted therapies in human cancers

  Relevance score: 0.00

  Didier Decaudin, Christophe Le Tourneau

  Keywords: targeted therapies, human cancers, preclinical studies, clinical trials

  Published in Aging on October 26, 2016